Please login to the form below

Not currently logged in
Email:
Password:

laquinimod

This page shows the latest laquinimod news and features for those working in and with pharma, biotech and healthcare.

Teva cuts 25% of workforce, with Israel taking a heavy toll

Teva cuts 25% of workforce, with Israel taking a heavy toll

be successor laquinimod and an underperformance in its generic drug operations that have only been amplified by adding the Actavis business.

Latest news

More from news
Approximately 4 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics